These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3955451)

  • 1. Prevalence of multiple sclerosis in British Columbia.
    Sweeney VP; Sadovnick AD; Brandejs V
    Can J Neurol Sci; 1986 Feb; 13(1):47-51. PubMed ID: 3955451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).
    Kingwell E; Zhu F; Marrie RA; Fisk JD; Wolfson C; Warren S; Profetto-McGrath J; Svenson LW; Jette N; Bhan V; Yu BN; Elliott L; Tremlett H
    J Neurol; 2015 Oct; 262(10):2352-63. PubMed ID: 26205633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of multiple sclerosis in Switzerland.
    Beer S; Kesselring J
    Neuroepidemiology; 1994; 13(1-2):14-8. PubMed ID: 8190201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada.
    McKay KA; Tremlett H; Zhu F; Kastrukoff L; Marrie RA; Kingwell E
    Eur J Neurol; 2016 Jun; 23(6):1093-100. PubMed ID: 26992124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan.
    Hader WJ; Yee IM
    Neurology; 2007 Sep; 69(12):1224-9. PubMed ID: 17875910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epidemiologic study of multiple sclerosis in Northern Ireland.
    McDonnell GV; Hawkins SA
    Neurology; 1998 Feb; 50(2):423-8. PubMed ID: 9484366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted clinical audits immediately following the establishment of clinical practice guidelines for multiple sclerosis in 17 neurology departments: A pragmatic and collaborative study.
    Lairy G; Zephir H; Ouallet JC; Le Page E; Laplaud D; Bensa C; De Seze J
    Rev Neurol (Paris); 2015 May; 171(5):407-14. PubMed ID: 25912471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of multiple sclerosis in Valladolid, northern Spain.
    Tola MA; Yugueros MI; Fernández-Buey N; Fernández-Herranz R
    J Neurol; 1999 Mar; 246(3):170-4. PubMed ID: 10323313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis in the Iranian immigrant population of BC, Canada: prevalence and risk factors.
    Guimond C; Lee JD; Ramagopalan SV; Dyment DA; Hanwell H; Giovannoni G; Criscuoli M; Yee IM; Vorobeychik G; Ebers GC; Sadovnick AD
    Mult Scler; 2014 Aug; 20(9):1182-8. PubMed ID: 24414537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
    Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demyelination and ethnicity: experience at the University of British Columbia Multiple Sclerosis Clinic with special reference to HTLV-I-associated myelopathy in British Columbian natives.
    Oger J; Lai H
    Ann Neurol; 1994; 36 Suppl():S22-4. PubMed ID: 8017884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible increasing risk of multiple sclerosis in Catania, Sicily.
    Nicoletti A; Patti F; Lo Fermo S; Sorbello V; Reggio E; Maimone D; Zappia M; Reggio A
    Neurology; 2005 Oct; 65(8):1259-63. PubMed ID: 16247054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of multiple sclerosis in Flanders, Belgium.
    van Ooteghem P; D'Hooghe MB; Vlietinck R; Carton H
    Neuroepidemiology; 1994; 13(5):220-5. PubMed ID: 7969706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).
    Shirani A; Zhao Y; Kingwell E; Rieckmann P; Tremlett H
    Mult Scler; 2012 Apr; 18(4):442-50. PubMed ID: 21952097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence survey of multiple sclerosis in the Australian Capital Territory.
    Simmons RD; Hall CA; Gleeson P; Everard G; Casse RF; O'Brien ED
    Intern Med J; 2001 Apr; 31(3):161-7. PubMed ID: 11478345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of multiple sclerosis in Iceland, 2002-2007: a population-based study.
    Eliasdottir OJ; Olafsson E; Kjartansson O
    Mult Scler; 2011 Aug; 17(8):909-13. PubMed ID: 21511690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of isolated optic neuritis in France: survey of neurologists and ophthalmologists].
    Calvetti O; Vignal-Clermont C; Drews-Botsch CD; Atkins EJ; Newman NJ; Biousse V
    Rev Neurol (Paris); 2008 Mar; 164(3):233-41. PubMed ID: 18405773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
    Kingwell E; Bajdik C; Phillips N; Zhu F; Oger J; Hashimoto S; Tremlett H
    Brain; 2012 Oct; 135(Pt 10):2973-9. PubMed ID: 22730559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of multiple sclerosis in 3 US communities.
    Noonan CW; Williamson DM; Henry JP; Indian R; Lynch SG; Neuberger JS; Schiffer R; Trottier J; Wagner L; Marrie RA
    Prev Chronic Dis; 2010 Jan; 7(1):A12. PubMed ID: 20040227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey.
    Papathanasopoulos P; Gourzoulidou E; Messinis L; Georgiou V; Leotsinidis M
    Neuroepidemiology; 2008; 30(3):167-73. PubMed ID: 18382116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.